Biotech entity

Suzanne

Person

pharma is the sole category represented across all 1 tracked stories. Suzanne is most often covered alongside Australian Fertility Clinics, which appears in 1 of these 1 story. We currently track 1 Biotech story that mention Suzanne, all published on March 8, 2026.

Last mentioned: Mar 8, 2026

Entity pulse

Recent coverage · Suzanne

1 story
5 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Suzanne

pharma is the sole category represented across all 1 tracked stories. Suzanne is most often covered alongside Australian Fertility Clinics, which appears in 1 of these 1 story. We currently track 1 Biotech story that mention Suzanne, all published on March 8, 2026. Each carries 2 original sources on average.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 10 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Suzanne. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Clinic Growth

    Rapid expansion of private equity-backed fertility clinic networks across Australia.

  2. Estimator Launch

    The independent egg freezing estimator is launched to provide realistic success projections to the public.

  3. Experimental Label Removed

    ASRM removes the 'experimental' label from egg freezing, leading to a surge in elective procedures.

Stories mentioning Suzanne 1

Pharma Neutral

New Australian Tool Provides Independent Reality Check on Egg Freezing Success

An independent Australian estimator tool has launched to provide women with realistic data on their chances of a successful live birth following egg freezing. By utilizing clinical data to counter commercial clinic optimism, the tool aims to improve informed consent in the rapidly growing fertility preservation market.

2 sources

Suzanne is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.